Amanta Healthcare Ltd
Amanta Healthcare Ltd (AMANTA) last reported results for the quarter ended Jun 2026, with sales of ₹68.8 crore and net profit of ₹3.31 crore. The stock last traded at ₹192, a market capitalisation of ₹744 crore, on a P/E of 48.5. Over the past 52 weeks the stock has ranged between ₹92 and ₹210. Figures are as of 6 Oct 2026 and are not real time.
Amanta Healthcare Ltd share price and key metrics
- Current price
- ₹192
- Market cap
- ₹744 cr
- Stock P/E
- 48.5
- Book value
- ₹56.7
- ROE
- 10.3%
- ROCE
- 11.6%
- Dividend yield
- 0.00%
- 52w high / low
- 210/92.0
Metrics as of 6 Oct 2026. Not real time.
Track Amanta Healthcare Ltd
Cruxal reads every Amanta Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Amanta Healthcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 4%
- TTM
- 7%
- 10 Years
- %
- 5 Years
- 22%
- 3 Years
- 114%
- TTM
- -4%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 45%
- 10 Years
- %
- 5 Years
- 4%
- 3 Years
- 10%
- Last Year
- 10%
Amanta Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹68.8 cr, up 5.3% from ₹65.31 cr a year earlier. Net profit was ₹3.31 cr, down 5.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 66.73 | 67.81 | 72.06 | 65.31 | 70.89 | 74.49 | 76.99 | 68.8 |
| Expenses | 52.85 | 52.75 | 53.1 | 50.41 | 56.24 | 59.13 | 62.03 | 54.26 |
| Operating profit | 13.88 | 15.06 | 18.96 | 14.9 | 14.65 | 15.36 | 14.96 | 14.54 |
| OPM % | 20.80% | 22.21% | 26.31% | 22.81% | 20.67% | 20.62% | 19.43% | 21.13% |
| Other income | 0.21 | 0.87 | 0.16 | 0.96 | -2.56 | 0.68 | 1.66 | 0.64 |
| Interest | 6.32 | 5.9 | 6.28 | 6.29 | 5.15 | 5.06 | 4.25 | 6 |
| Depreciation | 4.6 | 4.51 | 4.69 | 4.64 | 4.66 | 4.67 | 4.75 | 4.69 |
| Profit before tax | 3.17 | 5.52 | 8.15 | 4.93 | 2.28 | 6.31 | 7.62 | 4.49 |
| Tax % | 28.71% | 22.64% | 26.87% | 28.80% | 46.93% | 26.47% | 27.43% | 26.28% |
| Net profit | 2.26 | 4.28 | 5.96 | 3.51 | 1.21 | 4.63 | 5.53 | 3.31 |
| EPS (₹) | 0.78 | 1.48 | 2.07 | 1.22 | 0.31 | 1.19 | 1.42 | 0.85 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Amanta Healthcare Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 184 | 171 | 225 | 259 | 280 | 275 | 288 | 291 |
| Operating profit | 37 | 38 | 52 | 53 | 58 | 60 | 60 | 60 |
| OPM % | 20% | 22% | 23% | 20% | 21% | 22% | 21% | 20% |
| Net profit | -19 | -22 | 55 | -2 | 4 | 10 | 15 | 15 |
| EPS (₹) | -7.03 | -8.14 | 20.54 | -0.79 | 1.35 | 3.64 | 3.83 | 3.77 |
TTM is the trailing twelve months to the most recent quarter.
Amanta Healthcare Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 27 | 27 | 27 | 27 | 27 | 29 | 39 |
| Reserves | 2 | -20 | 36 | 36 | 39 | 68 | 181 |
| Borrowings | 231 | 235 | 226 | 216 | 211 | 204 | 244 |
| Other liabilities | 127 | 150 | 104 | 96 | 75 | 81 | 93 |
| Total liabilities | 388 | 392 | 392 | 374 | 352 | 382 | 558 |
| Fixed assets | 244 | 242 | 240 | 232 | 228 | 217 | 207 |
| CWIP | -0 | -0 | -0 | 9 | -0 | 7 | 82 |
| Investments | 0 | 2 | 3 | -0 | 4 | 8 | 7 |
| Other assets | 144 | 149 | 149 | 133 | 120 | 150 | 262 |
| Total assets | 388 | 392 | 392 | 374 | 352 | 382 | 558 |
As reported by the company. Total assets equal total liabilities by construction.
Amanta Healthcare Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 38 | 31 | 62 | 43 | 58 | 47 | 48 |
| Cash from investing | -9 | -13 | -6 | -7 | -10 | -24 | -94 |
| Cash from financing | -37 | -18 | -50 | -42 | -46 | -23 | 126 |
| Net cash flow | -8 | -0 | 6 | -6 | 1 | -1 | 81 |
| Free cash flow | 27 | 19 | 52 | 36 | 46 | 26 | -32 |
| CFO / operating profit | 102% | 66% | 119% | 93% | 111% | 84% | 93% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Amanta Healthcare Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 9% | 14% | 13% | 14% | 15% | 12% |
| Debtor days | 104 | 110 | 73 | 75 | 63 | 67 | 55 |
| Inventory days | 225 | 422 | 338 | 247 | 309 | 464 | 530 |
| Days payable | 99 | 186 | 185 | 130 | 129 | 194 | 230 |
| Cash conversion cycle | 229 | 345 | 226 | 193 | 243 | 336 | 354 |
| Working capital days | 51 | -5 | 28 | 42 | 16 | 26 | 6 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Amanta Healthcare Ltd shareholding pattern
Promoters held 63.79% at Jun 2026, broadly unchanged since Sep 2025. FIIs 0.43% and DIIs 12.92%.
| % held | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 63.56% | 63.56% | 63.72% | 63.79% |
| FIIs | 1.00% | 1.10% | 0.85% | 0.43% |
| DIIs | 11.34% | 11.24% | 12.88% | 12.92% |
| Public | 24.10% | 24.09% | 22.55% | 22.84% |
| No. of shareholders | 18,669 | 16,181 | 15,222 | 12,612 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Amanta Healthcare Ltd corporate filings
- Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Off-market transfer of 17.32 lakh equity shares by promoter group via gift, as per SEBI regulationsInsider Trading / SASTmedium impact
Cruxal's analysis: Amanta Healthcare Limited's promoter group has transferred 17.32 lakh equity shares…
Read the full analysis - Amanta Healthcare Ltd files disclosures for off-market transfer of equity shares under SEBI regulationsCompany Updatelow impact
Cruxal's analysis: The company submitted disclosures related to an off-market transfer of equity shares as…
Read the full analysis - Kirit Ambalal Desai announces off-market transfer of 150,400 equity shares (0.39%) of Amanta Healthcare Limited at Rs. 190 per share, effective September 28, 2026Insider Trading / SASTlow impact
Cruxal's analysis: Kirit Ambalal Desai, a promoter of Amanta Healthcare Limited, has executed an off-market…
Read the full analysis - Amanta Healthcare Limited disposes off 0.39% voting rights via off-market transfer to Promoter GroupInsider Trading / SASTlow impact
Cruxal's analysis: Amanta Healthcare Limited has executed an off-market transfer of 1.50 lakh equity shares…
Read the full analysis - Amanta Healthcare Ltd files disclosures under Regulation 7(2) for off-market transfer of equity sharesCompany Updatelow impact
Cruxal's analysis: On September 30, 2026, Amanta Healthcare Ltd submitted disclosures related to an…
Read the full analysis - Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015Insider Trading / SASTlow impact
- Amanta Healthcare Limited concludes 31st AGM; shareholders approve financial statements and revision in Managing Director's remunerationAGM/EGMlow impact
Cruxal's analysis: Amanta Healthcare Limited has successfully concluded its 31st Annual General Meeting held…
Read the full analysis - Amanta Healthcare Limited Announces Board Re-appointment and Appointment of Secretarial AuditorCompany Updatelow impact
Cruxal's analysis: Amanta Healthcare Limited has formally announced the re-appointment of Mr. Nimesh P…
Read the full analysis - Amanta Healthcare Limited concludes 31st Annual General Meeting; no adverse audit remarks reportedAGM/EGMlow impact
Cruxal's analysis: Amanta Healthcare Limited successfully conducted its 31st Annual General Meeting on…
Read the full analysis - Amanta Healthcare Ltd: Routine newspaper publication of financial results or corporate noticeCompany Updatelow impact
Cruxal's analysis: Amanta Healthcare Ltd has filed a disclosure regarding the publication of a notice in…
Read the full analysis - Amanta Healthcare commissions new SteriPort manufacturing lineCompany Updatemedium impact
Cruxal's analysis: Amanta Healthcare has officially commissioned a new SteriPort production line, marking an…
Read the full analysis - Amanta Healthcare Ltd: Intimation regarding Regulation 36(1)(b) of SEBI Listing RegulationsCompany Updatelow impact
Cruxal's analysis: Amanta Healthcare Ltd has filed a routine disclosure under Regulation 36(1)(b) of the…
Read the full analysis - Amanta Healthcare Ltd announces 31st Annual General Meeting and e-voting detailsCompany Updatelow impact
Cruxal's analysis: Amanta Healthcare has published a newspaper advertisement regarding the dispatch of its…
Read the full analysis - Amanta Healthcare Ltd releases Annual Report for Financial Year 2025-26Company Updatelow impact
Cruxal's analysis: Amanta Healthcare has filed its Annual Report for the financial year 2025-26, dated…
Read the full analysis - Amanta Healthcare Limited Announces 31st Annual General Meeting and Releases Annual Report 2025-26AGM/EGMhigh impact
Cruxal's analysis: Amanta Healthcare Limited has issued an intimation for its 31st Annual General Meeting…
Read the full analysis - Amanta Healthcare Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Amanta Healthcare has filed its Annual Report for the financial year 2025-26. The report…
Read the full analysis - Amanta Healthcare Ltd publishes newspaper advertisement for upcoming Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Amanta Healthcare Ltd has submitted newspaper clippings regarding the advertisement for…
Read the full analysis - Amanta Healthcare Q1 FY27 Earnings Call: Capacity Expansion and Margin OutlookCompany Updatehigh impact
Cruxal's analysis: Amanta Healthcare reported Q1 FY27 revenue of INR69 crore, a 5% YoY growth, with an…
Read the full analysis - Amanta Healthcare Ltd releases Monitoring Agency Report for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Amanta Healthcare Ltd has filed its Monitoring Agency Report for the quarter ended June…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.